EP 1357898 A2 20031105 - IMPROVED CONTROLLED RELEASE ORAL DOSAGE FORM
Title (en)
IMPROVED CONTROLLED RELEASE ORAL DOSAGE FORM
Title (de)
VERBESSERTE ORALE ARZNEIFORM MIT PROTRAHIERTER WIRKSTOFFREIGABE
Title (fr)
FORME POSOLOGIQUE ORALE A LIBERATION REGULEE AMELIOREE
Publication
Application
Priority
- US 0203523 W 20020208
- US 26745601 P 20010208
- US 26745701 P 20010208
Abstract (en)
[origin: WO02062299A2] A once a day bupropion hydrochloride formulation is disclosed.
[origin: WO02062299A2] A once a day bupropion hydrochloride formulation comprising applying a bupropion/cellulose ether suspension to inert spheres wherein the spheres are further divided and coated with two types of film being, an enteric coating and a hydrophobic coating, wherein the active drug is then released at various pH throughout the gastrointestinal tract maintaining a therapeutic range over an extended period of time.
IPC 1-7
IPC 8 full level
A61K 9/50 (2006.01); A61K 31/00 (2006.01); A61P 25/24 (2006.01); A61P 25/34 (2006.01)
CPC (source: EP)
A61K 9/5078 (2013.01); A61K 9/5084 (2013.01); A61P 25/24 (2017.12); A61P 25/34 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02062299 A2 20020815; WO 02062299 A3 20030424; CA 2433915 A1 20020815; CA 2433915 C 20100420; CA 2685214 A1 20020815; CA 2685214 C 20130122; CA 2796884 A1 20020815; EP 1357898 A2 20031105; EP 1357898 A4 20050713
DOCDB simple family (application)
US 0203523 W 20020208; CA 2433915 A 20020208; CA 2685214 A 20020208; CA 2796884 A 20020208; EP 02723104 A 20020208